Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound   Target Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound

---

Query: EC:3.1.3.1 (alkaline phosphatase)
47,916 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The fluoride (F) concentrations in hard tissues and blood plasma were determined in biopsy and autopsy specimens from fetuses, infants, and children on varying F intake. In newborn autopsy cases specimens consisting of rib, jawbone with teeth, and blood plasma the F concentrations of bone and dentin were of the same order, those of the enamel lower. Correlations between individual F values in different tissues were all positive, highest for enamel/dentin. Low birth weight entailed only slightly reduced F contents, high water F significantly increased F contents. In the biopsy material (rib and blood plasma) the maximal rib/ash concentration was about 400 parts/10(6) F. A negative correlation between rib F and plasma F is specially commented on. The possible influence of F on bone development as expressed by blood plasma F and phosphatase activity was investigated in three groups of infants aged 2-6 months, either breast-fed or fed dry-milk formulas diluted with drinking waters of different F content. The children of these groups were calculated to ingest F in the ratio of about 1:10:50. The highest F group had higher plasma F values than the two other groups, whereas its alkaline phosphatase was significantly higher than that of the lowest F group only. The influence of disturbances in the skeletal development on F retention studied in physically handicapped children aged 4-15 years living in a city with about 1 part/10(6) F in the drinking water. The severely handicapped showed a higher urinary F excretion than the controls.
...
PMID:Studies on fluoride distribution in infants and small children. 13 70

Dichloromethylene diphosphonate (Cl2MDP) antagonized the action of vitamin D on bone in thyroparathyroidectomized rats by reducing the metabolic activity of osteoblasts and osteocytes and decreasing the number of osteoclasts. Ultrastructurally, osteoblasts in Cl2MDP-treated rats were interpreted to be less active in bone matrix synthesis. Osteocytes in Cl2MDP-treated rats were interpreted ultrastructurally to be inactive; there was no evidence of bone resorption when compared to osteocytes in rats given vitamin D alone. Abnormal osmiophilic densities in the pericellular bone matrix of rats given vitamin D alone were not present in rats given vitamin D and Cl2MDP. The ultrastructure of osteoclasts was unaltered by Cl2MDT. These cellular changes were associated with a decrease in serum calcium and increase in bone ash and magnesium concentration in rats given high levels (10 mg/kg) of Cl2MDP. Bone adenosine triphosphatase and alkaline phosphatase activities were not affected by Cl2MDP. These results suggest that Cl2MDP may limit the hypercalcemia of hypervitaminosis D by directly inhibiting bone cells in addition to its physicochemical action.
...
PMID:Interaction of dichloromethylene diphosphonate and vitamin D on bone of thyroparathyroidectomized rats. 14 91

Dichloromethylene diphosphonate (Cl2MDP) was given at doses of 4 mg/kg and 10 mg/kg daily for 7 days to adult thyroparathyroidectomized rats fed a low calcium diet. Primary metaphyseal trabeculae in Cl2MDP-treated rats were more numerous and longer than in controls. The light and electron microscopic appearance of osteoblasts, osteocytes and osteoclasts were unaltered by Cl2MDP. Bone alkaline phosphatase was significantly elevated in rats given Cl2MDP but adenosine triphosphatase activity was unchanged. Bone fat-free weight, fat-free minus ash weight, and bone calcium and phosphorus concentration were reduced significantly in rats given 10 mg/kg Cl2MDP compared to controls. Bone magnesium concentration was significantly elevated in rats given 10 mg/kg Cl2MDP. Serum calcium and phosphorus concentration were lower in Cl2MDP-treated rats. These results suggest that Cl2MDP is capable of altering bone remodeling, enzyme activity and mineral content, without significantly altering bone cell morphology, independent of the effects of parathyroid hormone, calcitonin, and dietary calcium.
...
PMID:Effect of dichloromethylene diphosphonate on morphology, enzyme activity, and ash content of bones of thyroparathyroidectomized rats. 14 84

The effect of cadmium (1, 10, or 100 ppm) administered to male rats in drinking water for 13 weeks on body weight and mineral disposition (Cd, Mg, P and Zn) in several body tissues was examined. Most alterations observed in these parameters occurred only at the 100 ppm dose of Cd. Terminal body weight was decreased by 10% in rats ingesting Cd at 100 ppm resulting from decreased food intake since weight gain/food consumption ratio was the same for all treatment groups. In serum, cadmium ingestion resulted in an inhibition of alkaline phosphatase activity at all concentrations and phosphorous was elevated only in animals receiving 100 ppm Cd. No changes were observed in Ca in urea. In bone, Cd decreased zinc content, increased Ca content, but did not influence bone ash, Mg or P and roentgenographic examination revealed no bone abnormalities. In both liver and kidney, cadmium ingestion did not influence intestinal absorption of Ca, Mg, P, or Zn or the renal excretion of Ca, P, or urea. The results of this study indicate that alterations in body weight and tissue mineral disposition resulting from chronic Cd ingestion are dose-related.
...
PMID:Dose-related alterations in growth and mineral disposition by chronic oral cadmium administration in the male rat. 47 22

Pregnant rats were treated with 44, 88 and 176 Medical Research Council munits of thyrocalcitonin (TCT) twice daily during days 10 to 21 of gestation. Nonpregnant rats received the same treatment for 12 days. Administration of TCT to the pregnant rats increased the ash and calcium content of fetal bones and decreased the phosphorus content. The diaphyses were short and contained many persisting enchondral trabeculae and a reduced number of osteoclasts. TCT reduced the fetal intestinal alkaline phosphatase activity but elevated the intestinal calcium-binding protein content. In the pregnant and nonpregnant rats, treatment with TCT resulted in hypocalcemia and hypophosphatemia, and increased the calcium-binding protein content of the duodenal mucosa. In the fetuses, the calcium-binding protein content and alkaline phosphatase activity were higher in the jejunum and ileum than in the duodenum, and were much higher than the values found in adult animals. Our findings indicate that TCT passes through the rat placenta and affects the fetal skeleton and calcium metabolism directly, resulting primarily in decreased bone resorption.
...
PMID:Transplacental effects of thyrocalcitonin on intestinal calcium-binding protein, alkaline phosphatase activity and ossification of long bones in rat fetuses. 93 22

Young male rats were exposed to repeated heliox dives and analyzed for skeletal alterations. Animals were exposed 1, 3, 5, or 7 times to either 1 ATA He-O2 for 12.5 h, or to 5 ATA He-O2 for 4 h and a 8.5 h decompression, or to 5 ATA He-O2 for 4 h and a 1.5 h decompression. In a separate study, 30 rats were exposed 6 times to 5 ATA He-O2 and explosively decompressed. Animals were sacrificed 20 d after the last dive. There were no significant changes in femur wet weight, density, ash weight, length, or mineral content. Plasma calcium, phosphorus, and alkaline phosphatase remained normal. Eighteen of 30 animals survived the six explosive decompressions; however, there were no significant changes in bone. These results indicate that the number and rate of decompressions used in this study have no lasting effect on bone growth and mineral composition in the rat.
...
PMID:Skeletal response of rats to repeated short-term hyperbaric helium-oxygen exposures. 97 Nov 53

1. The effect of the osteolathyrogen aminoacetonitrile (AAN) on plasma calcium, phosphate and alkaline phosphatase, on bone, on growth rates, on absorption of calcium and phosphate in the gut and on their urinary excretion, has been examined in rats. 2. AAN caused a general deterioration in the health of the rat and reduced its rate of growth. 3. AAN reduced plasma calcium and increased plasma alkaline phosphatase but did not affect plasma phosphate. 4. AAN caused obvious deformity of the long bones with large exostoses. The femurs of the lathyritic rats had an increased fat-free weight and increased fat-free weight to ash weight ratio. 5. AAN increased true and apparent absorption of calcium but did not consistently affect urinary excretion of phosphate or apparent absorption of phosphate. 6. AAN did not produce a significant reduction in the plasma calcium of parathyroidectomized or thyroparathyroidectomized rats. 7. Absorption of calcium from ligated jejunal loops was increased in AAN-treated parathyroidectomized rats. 8. In some experiments parathyroidectomy or thyroparathyroidectomy protected the bones from the effect of AAN.
...
PMID:The effect of aminoacetonitrile on calcium metabolism and bone in the rat. 99 26

The effect of magnesium deficiency on phosphatase activity and bone composition was determined in the femora of young rats. In the right distal metaphysis the acid and alkaline phosphatase activities were decreased in magnesium-deficient rats, and the activity of bone alkaline phosphatase in the incubation mixture after adding magnesium was significantly greater in the magnesium-deficient than in the control rats. In the left distal metaphysis the water content was significantly lower in the magnesium-deficient rats at the fifth week but not at the third week. Conversely, the ash content of metaphyseal bone was significantly increased in magnesium-deficient rats at the fifth week, but not at the third week. The magnesium and phosphorus contents were abnormally low in the deficient bone at both periods. The calcium content was increased in the deficient bone at the third week, but not at the fifth week.
...
PMID:Bone composition and phosphatase activity in magnesium deficiency in rats. 114 Dec 63

Replacement of the drinking water of chicks maintained on a normal mixed protein diet with an aqueous extract containing the equivalent of 5 g of the dried leaves of Solanum malacoxylon (DLSM) per 100 ml for one month produces a hypercalcaemia (23-49 per cent), hypomagnesamia (28-37 per cent), hypophosphataemia (26-34 per cent), hypouricaemia (29-34 per cent) and a decrease in plasma alkaline phosphatase activity (54-98 per cent). The ash content of the defatted, dried tibiae and the body weight of the DLSM treated chicks were also significantly lower (37-7 per cent and 17-79 per cent respectively) than the corresponding values for the untreated birds. The results obtained are similar to those reported for hypervitaminosis D3 in the chick.
...
PMID:The effect of the administration of Solanum malacoxylon on the chick. 114 27

Two strains of broiler chickens selected for a high and a low incidence of tibial dyschondroplasia were fed a standard broiler starter ration with and without added chloride. Development of tibial dyschondroplasia was studied by radiography and serial necropsies. Lesions of tibial dyschondroplasia were mild in the low-incidence strain, regardless of ratio. The defect was more severe in the high-incidence strain and most severe in those birds fed the high-chloride ration. An abnormal thickening of the growth plate was apparent in the high-incidence strain as early as 2 weeks of age and became progressively more severe with age. No significant differences were noted in serum calcium, phosphorus, alkaline phosphatase, pCO2, or bone ash between strains of birds or between birds of the same strain fed different rations. Birds fed the high-chloride ration had a higher serum chloride and a lower serum bicarbonate and blood pH than birds on the standard ration.
...
PMID:The development of tibial dyschondroplasia in broiler chickens. 116 13


1 2 3 4 5 6 7 8 9 10 Next >>

---